hero image
Follow us!

Any effective drug pricing reform must lower the drug prices that patients actually pay, independent of whether or not such reforms – given the complex nature of the prescription drug supply chain – actually lower list prices. 

Patients Rising Now welcomes the proposed changes by the Trump Administration aiming to lower costs for patients by targeting backdoor rebates and encouraging direct discounts to those who receive their health care through Medicare/Medicaid. 

Patients Rising Now applauds the proposed legislation by both the Virginia Senate (SB 1596) and Virginia House (HB 2515) banning the use of copay accumulator adjustment programs in the state, protecting Virginians